M-tron: The Order Book Says 2028, the Tape Says Wait
MPTI printed record margins and pointed at $127 billion of upstream missile awards — but pushed the backlog inflection into Q1 2027 and watched the whole defense-tech cohort de-rate 30%
MPTI · Earnings Call · 2026-11-12
A 36% Drawdown Into the Best Numbers the Company Has Printed
M-tron Industries makes the frequency and timing guts of things that go boom: oven-controlled oscillators, RF subassemblies, radar and electronic-warfare components. In Q3 FY2026 it reported $15.7M of revenue (+11.1% yoy), a 44.5% gross margin, $3.0M of net income ($0.70 diluted versus $0.60), and $3.6M of adjusted EBITDA. Management called out radar and electronic warfare as growing at "well over 100%," with radar demand now the company's most-cited forward theme. And the stock is down 26.6% over 90 days and 36% from its July 1 peak of $100.75. That split is not a company-specific protest — it is the cohort. Over the trailing 90 days the tape has punished exactly this kind of business: Air Defense System names off roughly 29% (RHM.DE, DRS, KTOS, RTX), counter UAS systems off 24%, space domain awareness off 31%. The 360-day window still shows defense-adjacent clusters like "defense end market" advancing; the last 90 days flipped the sign. MPTI is being priced as a member of a de-rating group, not on the strength of its own bookings.Nothing Broke. Everything Slipped.
The single most important sentence on the call was a scheduling sentence. Asked about programs being bid, the CEO described a budget process in flux, then said the orders land "after the new Congress is seated" — a phrase that maps almost exactly onto the market-wide new Congress theme that sits near the top of the global keyword board this quarter. MPTI's own defense budget keyword leads its company list, and the text around it is not celebratory, it is procedural: the FY27 budget is unsigned, the administration has split approvals across three mechanisms, and POs that were expected in Q3 or Q4 of 2026 have been re-phased into the new year.So the answer to "is the missile replenishment real?" is yes — and it was made concretely this quarter: over $127 billion of contract awards with Raytheon and Lockheed across PAC-3, Tomahawk, SM-3 IB, SM-6 and AMRAAM, most of them five-year production agreements with explicit volume growth. The framework agreements signed in early spring have converted into contracts. But the conversion from prime contract to M-tron purchase order is the part that moved. The consequence is a guidance shape that requires patience: backlog likely declines in Q4, then strengthens "quite a bit" in Q1 2027, then drives 2027 acceleration and, per the CEO, 2028 growth "probably in the high teens." Note that Q3's +11.1% was actually a touch slower than the +14% year-over-year in the July quarter, and the sequential step from $15M to $15.7M was modest. The acceleration is entirely forward-dated and entirely contingent on POs not yet in hand.we do anticipate winning our fair share of those engagements. And we think we'll see those POs early in the coming year, so, after the new Congress is seated... I do anticipate that our backlog will grow significantly at that point in time.
The Capacity Tell
What is unusual this quarter is that management stopped talking about handling backlog and started talking about concrete and steel. The recurring capacity line — “we have more backlog than we can produce in the quarter” — Cameron Pforr, CEO · 2026-11-12 — was nearly identical in August, but the follow-through is new: Orlando expansion underway, and “if some of these purchase orders come in at the growth rate that has been discussed at least in the press, that could lead to us having to create a new facility” — Cameron Pforr, CEO · 2026-11-12 sometime around 2029-2030. The phrase new facility is new to this company's keyword set, and it is the honest tell that the demand curve being described is bigger than the current footprint. That shows up in spending. Capital expenditure was $937K in the July quarter alone, with the CEO putting FY26 above $4M, roughly 7-8% of revenue and about double the prior run rate. Against total revenue that is a capital intensity closer to an industrial ramp than a component shop.The Taboo Word
Tariffs have vanished. For four straight calls — through the March 2026 call — tariffs were a named gross-margin drag, quantified at roughly 1% of revenue, with a discussion of pass-through clauses. In the August 2026 call the guidance was explicit and cautious:Q3 came in at 44.5%, above the top of that range, and the word "tariff" does not appear in the prepared remarks at all. Impact from tariffs, the single highest-ranked keyword in the 2025 Q3 call for this company, has quietly left the narrative. This is a genuine positive operating inflection — the new-product ramp inefficiencies that hurt 2025 have been solved — but the guidance that follows is deliberately humble: 43-46% for FY27, with “I imagine our gross margin will be down a little bit” — Cameron Pforr, CEO · 2026-11-12 as production scales. Read that as management pre-committing to a building year rather than a margin year.with the tariffs continuing we probably are going to see gross margins in the back half of the year, somewhere in the, you know, maybe 41.5 to 43.5 range, maybe 44%. But, certainly not any higher than that.